Latest
Antibiotic Ineffective Against Citrus Greening: Study
Antibiotic Ineffective Against Citrus Greening: Study
Ashley P. Taylor | Aug 19, 2019
Oxytetracycline, approved by the US government to combat citrus scourge, may not work—at least not as a spray.
HIV-1 Genome Extracted from 1966 Tissue Sample
HIV-1 Genome Extracted from 1966 Tissue Sample
Nicoletta Lanese | Aug 19, 2019
Scientists spent five years reconstructing what is now the oldest HIV-1 genome yet recovered.
Immune Cell Bank Bets on Future CAR T Success
Immune Cell Bank Bets on Future CAR T Success
Nicoletta Lanese | Aug 16, 2019
The company Cell Vault offers to hold consumers’ T cells for later use, but scientists suggest the service would benefit very few users.
Special Schwann Cells in Mice Play Unsung Role in Pain
Special Schwann Cells in Mice Play Unsung Role in Pain
Nicoletta Lanese | Aug 16, 2019
The glia seem to make up part of a newly described sensory organ, the discoverers suggest.
Chemist Richard Van Duyne Dies
Chemist Richard Van Duyne Dies
Catherine Offord | Aug 16, 2019
The Northwestern University professor developed surface-enhanced Raman spectroscopy, an invaluable technique for detecting and identifying individual molecules.
Exercise Changes Our Gut Microbes, But How Isn’t Yet Clear
Exercise Changes Our Gut Microbes, But How Isn’t Yet Clear
Ashley Yeager | Aug 15, 2019
Physical activity, independent of diet, shifts the composition of bacteria in the intestines, spurring researchers to search for species that might provide benefits akin to working out.
JHU Researchers Harmed Dogs, Animal Rights Group Argues
JHU Researchers Harmed Dogs, Animal Rights Group Argues
Ashley Yeager | Aug 15, 2019
Stop Animal Exploitation Now issues a federal complaint against Johns Hopkins scientists, saying they messed up surgeries on nine animals.
First New Tuberculosis Drug Approved in 50 Years
First New Tuberculosis Drug Approved in 50 Years
Jef Akst | Aug 15, 2019
The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.
Leaders of AveXis Out Over Doctored Gene Therapy Data
Leaders of AveXis Out Over Doctored Gene Therapy Data
Kerry Grens | Aug 14, 2019
Novartis, which bought the biotech firm in 2018, announced that the company’s top scientists have left, and news reports say it’s because they were involved in using manipulated data to get the gene therapy Zolgensma approved.